About
Technology
Issues
FAQ
Links
Official Page
Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.